Carterra Announces Multiple Sales of its New LSA™ Array SPR Instrument for Comprehensive Monoclonal Antibody Characterization
First LSA instrument sales are to a broad range of initial customers, including large pharmaceutical, biotech, CRO and academic institutions.
Carterra Inc. Raises $10M from Telegraph Hill Partners to Develop and Launch Next-Generation Antibody Characterization Platform
Additional Resources Will Drive Commercialization of Novel High-Throughput Label-Free Biosensor for Streamlined Antibody Characterization.
GEN Tutorial on High Throughput Antibody Characterization
Learn about epitope binning for next-generation biotherapeutic discovery.
Wasatch Microfluidics Announces Name Change to Carterra Inc. and New High Throughput SPR Instrument
New corporate name and system reflect the evolution of the Company into a premier provider of biotherapeutic characterization tools.